Growth Hormone and Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00190359
Recruitment Status : Terminated
First Posted : September 19, 2005
Last Update Posted : September 19, 2005
Information provided by:
Assistance Publique - Hôpitaux de Paris

Brief Summary:
Heart failure induces modification in several neurohormonal systems. The aim of this study is to determine if the growth hormone/IGF1 axis is modified in heart failure patients compared to healthy volunteers.

Condition or disease
Heart Failure, Congestive

Detailed Description:
One hundred and sixty three heart failure patients were evaluated by clinical examination, echocardiography, exercise test and measurement of blood BNP. Growth hormone and IGF-1 plasma levels were determined in each patient. The same biological measurements were performed in a group of 148 healthy controls. Comparisons were performed between groups for Growth hormone plasma level, IGF-1 plasma level and Growth hormone/IGF-1 index. A correlation between the severity of heart failure and the different biological parameters was searched.

Study Type : Observational
Enrollment : 180 participants
Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective
Official Title: Modifications of the Growth Hormone/IGF1 Axis in Heart Failure Patients
Study Start Date : September 2000
Study Completion Date : February 2003

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Heart failure patients in stable condition

Exclusion Criteria:

  • cancer
  • pituitary disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00190359

Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Principal Investigator: Patrick Maison, MD, PhD APHP Identifier: NCT00190359     History of Changes
Other Study ID Numbers: CRC00007
First Posted: September 19, 2005    Key Record Dates
Last Update Posted: September 19, 2005
Last Verified: April 2002

Keywords provided by Assistance Publique - Hôpitaux de Paris:
heart failure
growth substances

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs